Meihua International Medical Technologies Co., Ltd. (MHUAF) — SEC Filings
Meihua International Medical Technologies Co., Ltd. (MHUAF) — 22 SEC filings. Latest: 6-K (Dec 16, 2025). Includes 19 6-K, 2 20-F, 1 SC 13G.
View Meihua International Medical Technologies Co., Ltd. on SEC EDGAR
Overview
Meihua International Medical Technologies Co., Ltd. (MHUAF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 16, 2025: Meihua International Medical Technologies Co., Ltd. filed a 6-K, indicating they are furnishing an English translation of their 2023 Annual Report on Form 20-F, which was filed with the SEC on April 26, 2024. This filing is routine and provides shareholders with access to the company's detailed fina
Sentiment Summary
Across 22 filings, the sentiment breakdown is: 2 bearish, 19 neutral, 1 mixed. The dominant filing sentiment for Meihua International Medical Technologies Co., Ltd. is neutral.
Filing Type Overview
Meihua International Medical Technologies Co., Ltd. (MHUAF) has filed 19 6-K, 2 20-F, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (22)
Risk Profile
Risk Assessment: Of MHUAF's 18 recent filings, 1 were flagged as high-risk, 6 as medium-risk, and 11 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Yongjun Liu
- Xin Wang
- Steven Wang
Industry Context
Meihua International Medical Technologies operates in the medical instruments and apparatus industry, a sector focused on the development and manufacturing of healthcare devices.
Top Tags
regulatory-filing (4) · annual-report (3) · corporate-governance (3) · foreign-private-issuer (3) · delisting-risk (3) · shareholder-meeting (2) · management-change (2) · 6-K (2) · sec-filing (2) · agm (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-41291 | Identifies the specific SEC filing for Meihua International Medical Technologies Co., Ltd. |
| Fiscal Year End | 2024 | The period covered by the annual report. |
| Filing Date | 20250425 | The date the 20-F was submitted to the SEC. |
| Minimum Bid Price | $1.00 | The threshold the company's stock price has fallen below, leading to non-compliance with Nasdaq listing rules. |
| Share Repurchase Authorization | $3.0M | Maximum amount the company is authorized to spend on repurchasing its shares. |
| Outstanding Shares | 23,940,000 | As of December 31, 2023 |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Meihua International Medical Technologies Co., Ltd. (MHUAF)?
Meihua International Medical Technologies Co., Ltd. has 22 recent SEC filings from Jan 2024 to Dec 2025, including 19 6-K, 2 20-F, 1 SC 13G. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MHUAF filings?
Across 22 filings, the sentiment breakdown is: 2 bearish, 19 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Meihua International Medical Technologies Co., Ltd. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Meihua International Medical Technologies Co., Ltd. (MHUAF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Meihua International Medical Technologies Co., Ltd.?
Financial highlights for Meihua International Medical Technologies Co., Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for MHUAF?
The investment thesis for MHUAF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Meihua International Medical Technologies Co., Ltd.?
Key executives identified across Meihua International Medical Technologies Co., Ltd.'s filings include Yongjun Liu, Xin Wang, Steven Wang.
What are the main risk factors for Meihua International Medical Technologies Co., Ltd. stock?
Of MHUAF's 18 assessed filings, 1 were flagged high-risk, 6 medium-risk, and 11 low-risk.
What are recent predictions and forward guidance from Meihua International Medical Technologies Co., Ltd.?
Forward guidance and predictions for Meihua International Medical Technologies Co., Ltd. are extracted from SEC filings as they are enriched.